Advancing Advocacy in MS: Access to Affordable, High-Quality Care and Treatments
Wednesday, June 1 at 8:00 am

Delivering Patient-Centered, Equitable Multiple Sclerosis Care: The Latest Evidence and Real-World Perspectives
Wednesday, June 1 at 9:45 am

What Can Biomarkers Tell Us? Modern Tools to Assist Navigating Prognosis, Monitoring, and Therapeutic Decision-Making in the Long-Term Management of Multiple Sclerosis
Wednesday, June 1 at 4:00 pm

New Developments in Neuromyelitis Optica Spectrum Disorder: Expert Guidance on Diagnosis, Treatment Strategies, and the Patient Perspective
Wednesday, June 1 at 8:00 pm

Innovations and Imaging in Multiple Sclerosis: Examining the Evidence, Looking Toward the Future of Bruton Tyrosine Kinase Inhibitors
Thursday, June 2 at 7:00 am

Re-Examining S1PR Modulation From All Angles in Relapsing Multiple Sclerosis
Impact on Physical and Cognitive Outcomes, and Practical Considerations of Long-Term Therapy
Friday, June 3 at 7:00 am

Neuromyelitis Optica Spectrum Disorder: A Novel Therapeutic Landscape and Its Impact on Treatment Paradigms
Friday, June 3 at 6:45 pm

The Changing Face of Multiple Sclerosis: Addressing the Demographic Shift Towards Elderly Patients
Saturday, June 4 at 7:00 am


To register for an symposium visit